Promising Nanotechnology Stocks to Watch

According to recent findings from a stock screener tool, OSI Systems, Virpax Pharmaceuticals, and NVE are three notable nanotechnology stocks that investors should keep an eye on. These nanotechnology stocks are shares in companies dedicated to researching, developing, and commercializing products linked to nanoscale science and engineering. The firms in this sector are making significant advancements in areas such as materials science, electronics, and healthcare, where innovations at the atomic and molecular levels hold the promise of substantial improvements in performance and efficiency. The stocks highlighted recently had the highest trading volume among nanotechnology stocks in the preceding days.

OSI Systems (OSIS)

OSI Systems, Inc. focuses on designing and manufacturing electronic systems and components. The company is divided into three main segments: Security, Healthcare, and Optoelectronics and Manufacturing. In the Security segment, OSI Systems provides a variety of services which include baggage and parcel inspection, screening of cargo and vehicles, and systems that monitor radiation as well as explosive and narcotics detection systems under the Rapiscan brand.

On Friday, shares of NASDAQ: OSIS fell by $3.65 to reach $193.78 during midday trading. The trading volume for the day was 337,321 shares, significantly exceeding its average of 170,122 shares. The firm's fifty-day simple moving average stands at $192.85, while the two-hundred-day simple moving average is $168.82. OSI has a debt-to-equity ratio of 0.56, a current ratio of 1.88, and a quick ratio of 1.25. Over the past year, the stock has traded between a low of $126.57 and a high of $220.00. The company is valued at approximately $3.26 billion and has a price-to-earnings ratio of 24.94, alongside a price-to-earnings-growth ratio of 1.81 and a beta of 1.20.

Virpax Pharmaceuticals (VRPX)

Virpax Pharmaceuticals, Inc. is currently in the preclinical stage of pharmaceutical development, focusing on various drug-delivery systems and technologies for releasing medications. The company aims to advance alternatives for pain management that are non-opioid and non-addictive. Their preclinical products include Epoladerm, a topical spray film technology targeting osteoarthritis pain; Probudur, a liposomal gel that serves as an injectable local anesthetic for postoperative pain; and Envelta, a novel intranasal spray that uses nanotechnology to deliver a metabolically labile peptide drug to the brain.

On Friday, shares of Virpax Pharmaceuticals experienced a decline of $0.43, closing at $2.07. A total of 2,207,175 shares exchanged hands on that day, far exceeding an average volume of 175,217. The stock's 50-day moving average stands at $0.29, while its 200-day moving average is $0.47. In the past year, the stock saw a low of $1.85 and a high of $107.50.

NVE (NVEC)

NVE Corporation creates and sells devices that utilize spintronics, a specific type of nanotechnology that leverages electron spin for information acquisition, storage, and transmission. The company manufactures a range of spintronic products, including sensors and couplers that are essential for data management.

On Friday, NASDAQ: NVEC saw an increase of $0.59 and reached $65.99. The trading volume for the day was 47,414 shares, compared to an average of 20,701 shares. NVE has recorded a fifty-two week low of $63.65 and a high of $90.24. The company's 50-day moving average price is $71.42, while its 200-day moving average price is $76.14. With a market cap of $319.19 million, NVE holds a price-to-earnings ratio of 21.29 and a beta of 1.08.

Investing, Nanotechnology, Stocks